Gaya S. Dasanayake

Gaya S. Dasanayake

Auto-generated profile, based on publicly available information

Gaya S. Dasanayake

Department of Chemistry & Biochemistry, The University of Mississippi, University, MS 38677, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
CHChristine M. Hamadani
Christine M. Hamadani
ICIndika Chandrasiri
Indika Chandrasiri
MYMahesh Loku Yaddehige
Mahesh Loku Yaddehige
GDGaya S. Dasanayake
Gaya S. Dasanayake
IOIyanuoluwani Owolabi
Iyanuoluwani Owolabi
ETEden E. L. Tanner
Eden E. L. Tanner
Linear-dendritic block copolymers (LDBCs) have emerged as promising materials for drug delivery applications, with their hybrid structure exploiting advantageous properties of both linear and dendritic polymers. LDBCs have promising encapsulation efficiencies that can be used to encapsulate both hydrophobic and hydrophilic dyes for bioimaging, cancer therapeutics, and small biomolecules. Additionally, LDBCS can be readily functionalized with varying terminal groups for more efficient targeted delivery. However, depending on structural composition and surface properties, LDBCs also exhibit high dispersities (Đ), poor shelf-life, and potentially high cytotoxicity to non-target interfacing blood cells during intravenous drug delivery. Here, we show that choline carboxylic acid-based ionic liquids (ILs) electrostatically solvate LDBCs by direct dissolution and form stable and biocompatible IL-integrated LDBC nano-assemblies. These nano-assemblies are endowed with red blood cell-hitchhiking capabilities and show altered cellular uptake behavior ex vivo. When modified with choline and trans-2-hexenoic acid, IL-LDBC dispersity dropped by half compared to bare LDBCs, and showed a significant shift of the cationic surface charge towards neutrality. Proton nuclear magnetic resonance spectroscopy evidenced twice the total amount of IL on the LDBCs relative to an established IL-linear PLGA platform. Transmission electron microscopy suggested the formation of a nanoparticle surface coating, which acted as a protective agent against RBC hemolysis, reducing hemolysis from 73% (LDBC) to 25% (IL-LDBC). However, dramatically different uptake behavior of IL-LDBCs vs. IL-PLGA NPs in RAW 264.7 macrophage cells suggests a different conformational IL-NP surface assembly on the linear versus the linear-dendritic nanoparticles. These results suggest that by controlling the physical chemistry of polymer-IL interactions and assembly on the nanoscale, biological function can be tailored toward the development of more effective and more precisely targeted therapies.

22 February 2024 in Nanoscale
Verified
Journal Article
Open access
PDF file
GDGaya S. Dasanayake
Gaya S. Dasanayake
CHChristine M. Hamadani
Christine M. Hamadani
GSGagandeep Singh
Gagandeep Singh
SMSandeep Kumar Misra
Sandeep Kumar Misra
PVPriyavrat Vashisth
Priyavrat Vashisth
ETEden E. L. Tanner
Eden E. L. Tanner
Zwitterionic liquid surface-modified PEG–PLGA nanoparticles are developed to explore their potential as intravenous drug delivery carriers via RBC hitchhiking and affinity towards triple-negative breast cancer cells.

1 January 2021 in Gut Microbes
Verified
Journal Article
Open access
AFAlyssa C. Fasciano
Alyssa C. Fasciano
GDGaya S. Dasanayake
Gaya S. Dasanayake
MEMary K. Estes
Mary K. Estes
NZNicholas C. Zachos
Nicholas C. Zachos
DBDavid T. Breault
David T. Breault
JMJoan Mecsas
Joan Mecsas
Many pathogens use M cells to access the underlying Peyer’s patches and spread to systemic sites via the lymph as demonstrated by ligated loop murine intestinal models. However, the study of interactions between M cells and microbial pathogens has stalled due to the lack of cell culture systems. To overcome this obstacle, we use human ileal enteroid-derived monolayers containing five intestinal cell types including M cells to study the interactions between the enteric pathogen, Yersinia pseudotuberculosis (Yptb), and M cells. The Yptb type three secretion system (T3SS) effector Yops inhibit host defenses including phagocytosis and are critical for colonization of the intestine and Peyer’s patches. Therefore, it is not understood how Yptb traverses through M cells to breach the epithelium. By growing Yptb under two physiological conditions that mimic the early infectious stage (low T3SS-expression) or host-adapted stage (high T3SS-expression), we found that large numbers of Yptb specifically associated with M cells, recapitulating murine studies. Transcytosis through M cells was significantly higher by Yptb expressing low levels of T3SS, because YopE and YopH prevented Yptb uptake. YopE also caused M cells to extrude from the epithelium without inducing cell-death or disrupting monolayer integrity. Sequential infection with early infectious stage Yptb reduced host-adapted Yptb association with M cells. These data underscore the strength of enteroids as a model by discovering that Yops impede M cell function, indicating that early infectious stage Yptb more effectively penetrates M cells while the host may defend against M cell penetration of host-adapted Yptb.

23 February 2024 in Journal of Materials Chemistry C
Verified
Journal Article
Open access
PDF file
NSNicholas E. Sparks
Nicholas E. Sparks
CSCameron Smith
Cameron Smith
TSTerrence Stahl
Terrence Stahl
DADhanush L. Amarasekara
Dhanush L. Amarasekara
CHChristine Hamadani
Christine Hamadani
Davita L. Watkins Davita L. Watkins
Davita L. Watkins
Fluorescence bioimaging with near-infrared II (NIR-II) emissive organic fluorophores has proven to be a viable noninvasive diagnostic technique. However, there is still the need for the development of fluorophores that possess increased stability as well as functionalities that impart stimuli responsiveness. Through strategic design, we can synthesize fluorophores that possess not only NIR-II optical profiles but also pH-sensitivity and the ability to generate heat upon irradiation. In this work, we employ a donor–acceptor–donor (D–A–D) design to synthesize a series of NIR-II fluorophores. Here we use thienothiadiazole (TTD) as the acceptor, 3-hexylthiophene (HexT) as the π-spacer and vary the alkyl amine donor units: N,N-dimethylaniline (DMA), phenylpiperidine (Pip), and phenylmorpholine (Morp). Spectroscopic analysis shows that all three derivatives exhibit emission in the NIR-II region with λemi max ranging from 1030 to 1075 nm. Upon irradiation, the fluorophores exhibited noticeable heat generation through non-radiative processes. The ability to generate heat indicates that these fluorophores will act as theranostic (combination therapeutic and diagnostic) agents in which simultaneous visualization and treatment can be performed. Additionally, biosensing capabilities were supported by changes in the absorbance properties while under acidic conditions as a result of protonation of the alkyl amine donor units. The fluorophores also show minimal toxicity in a human mammary cell line and with murine red blood cells. Overall, initial results indicate viable NIR-II materials for multiple biomedical applications.

27 September 2023 in Materials Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
GSGagandeep Singh
Gagandeep Singh
GDGaya S. Dasanayake
Gaya S. Dasanayake
CCClaylee M. Chism
Claylee M. Chism
PVPriyavrat Vashisth
Priyavrat Vashisth
AKAmandeep Kaur
Amandeep Kaur
ETEden E. L. Tanner
Eden E. L. Tanner
Achieving safe and efficacious drug delivery is still an outstanding challenge. Herein we have synthesized 20 biocompatible good's buffer-based ionic liquids (GBILs) with a range of attractive properties for drug delivery applications. The synthesized GBILs were used to coat the surface of poly(lactic-co-glycolic acid) (PLGA) by nanoprecipitation-sonication and characterized by dynamic light scattering (DLS) and proton nuclear magnetic resonance (1H NMR) spectroscopy. The GBIL-modified PLGA NPs were then tested for their interaction with bio-interfaces such as serum proteins (using SDS-PAGE and LCMS) and red blood cells (RBCs) isolated from human and BALB/c mouse blood. In this report, we show that surface modification of PLGA with certain GBILs led to modulation of preferential cellular uptake towards human triple-negative breast cancer cells (MDA-MB-231) compared to human normal healthy breast cells (MCF-10A). For example, cholinium N,N-bis(2-hydroxyethyl)-2-aminoethane sulfonate (CBES) coated PLGA NPs were found to be selective for MDA-MB-231 cells (60.7 ± 0.7%) as compared to MCF-10A cells (27.3 ± 0.7%). In this way, GBIL-coatings have increased PLGA NP uptake in the cancer cells by 2-fold while decreasing the uptake towards normal healthy breast cells. Therefore, GBIL-modified nanoparticles could be a versatile platform for targeted drug delivery and gene therapy applications, as their surface properties can be tailored to interact with specific cell receptors and enhance cellular uptake. This formulation technique has shown promising results for targeting specific cells, which could be explored further for other cell types to achieve site-specific and efficient delivery of therapeutic agents.

11 July 2025 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
CHChristine M. Hamadani
Christine M. Hamadani
GTGeorge R. Taylor
George R. Taylor
ACAmber Cecil
Amber Cecil
CCClaylee M. Chism
Claylee M. Chism
EHEmilia Huff
Emilia Huff
ETEden E. L. Tanner
Eden E. L. Tanner
We explore the mechanism behind in situ red blood cell hitchhiking by ionic liquid-coated nanoparticles, which can be leveraged for targeted drug delivery.